Evidence map · PBM · Alzheimer’s disease and MCI
PBM for Alzheimer’s disease and MCI: what the research shows
Photobiomodulation for Alzheimer’s disease and MCI. 77 papers from 2016 to 2026, including 1 meta-analyses, 8 systematic reviews and 13 randomised controlled trials. Each study below links to its source.
77Papers in the corpus
1Meta-analyses
13Randomised controlled trials
57Open-access papers
Study design
Jev labels21 papers have no confident study-design label yet. Labels are AI-classified by Jev: advisory, not clinician-reviewed.
Papers over time
by publication year* 2026 is still in progress, so its count is incomplete.
Most-cited trials and reviews
by citations- 1
Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review.
- 2
Phototherapy for Cognitive Function in Patients With Dementia: A Systematic Review and Meta-Analysis.
- 3
Can transcranial photobiomodulation improve cognitive function in TBI patients? A systematic review.
- 4
The effect of transcranial photobiomodulation on cognitive function and attentional performance of older women with mild cognitive impairment: a randomized controlled trial.
- 5
The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study.
Recent trials and reviews
last 3 years- 1
The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study.
- 2
Can transcranial photobiomodulation improve cognitive function in TBI patients? A systematic review.
Decision support only. This page summarises published literature; it is not medical advice or a recommendation for any patient. Study designs and topic labels are AI-classified by Jev: advisory, not clinician-reviewed. Abstracts are not reproduced here: follow the links to read each source. Data snapshot 2026-09-25.